About A.J. (Amanda) Holst
Introduction
The aim of this PhD project, which I began on September 1, 2024, is to explore the 3D printing of pediatric medicines. 3D printing technology enables the creation of medications with a wide range of dosages, shapes, flavors, and drug combinations, all customized to meet the unique needs of individual patients and specific disease conditions. Our plan is to develop a portfolio of 10 printable medicines.
Field(s) of expertise
- 3D printing
- Bio-Pharmaceutical sciences
Education and career
Completed the bachelor Bio-Pharmaceutical Sciences in 2021. Completed the Master Bio-Pharmaceutical Sciences in 2024, with both a research specialization and a business specialization. I completed my final research internship at the Erasmus MC Hospital Pharmacy, where I focused on measuring antibiotic concentrations at the site of infection in patients with periprosthetic joint infections.
Publications
-
'Quantification of cefuroxime and flucloxacillin in synovial tissue and bone using ultra-performance convergence chromatography-tandem mass spectrometry', Journal of Chromatography B.
